Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Related Citations for PubMed (Select 23473090)

1.

Acute glaucoma in a patient with an Artisan® due to trabecular blockage after combined intravitreal treatment for macular oedema.

Valverde-Megías A, Donate-López J, Torres-Imaz R, Díaz Valle D, Arriola-Villalobos P, Jiménez-Santos M, García-Feijoo J.

Arch Soc Esp Oftalmol. 2013 Mar;88(3):120-2. doi: 10.1016/j.oftal.2012.02.003. Epub 2012 Jul 20. English, Spanish.

PMID:
23473090
2.

Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.

Gokce G, Sobaci G, Durukan AH, Erdurman FC.

Postgrad Med. 2013 Sep;125(5):51-8. doi: 10.3810/pgm.2013.09.2699.

PMID:
24113663
3.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
4.

Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.

Higashiyama T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ohji M.

Acta Ophthalmol. 2013 Jun;91(4):318-24. doi: 10.1111/j.1755-3768.2011.02298.x. Epub 2011 Dec 1.

PMID:
22132711
5.

Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.

Lim JW, Lee HK, Shin MC.

Ophthalmologica. 2012;227(2):100-6. doi: 10.1159/000331935. Epub 2011 Oct 12.

PMID:
21997197
6.

[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].

Jonas JB, Kreissig I, Degenring RF.

Klin Monbl Augenheilkd. 2003 Jun;220(6):384-90. Review. German.

PMID:
12830391
7.

Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.

Schulze-Döbold C, Weber M.

Int Ophthalmol. 2009 Oct;29(5):427-9. doi: 10.1007/s10792-008-9248-9. Epub 2008 Jul 10.

PMID:
18618083
8.

[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Jonas JB, Kreissig I, Kamppeter B, Degenring RF.

Ophthalmologe. 2004 Feb;101(2):113-20. Review. German.

PMID:
14991306
9.

Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.

Taş M, Oner V, Alakuş MF, Türkcü FM, Işcan Y, Yüksel K.

Int Ophthalmol. 2013 Aug;33(4):375-80. doi: 10.1007/s10792-012-9709-z. Epub 2013 Jan 19.

PMID:
23334618
10.

Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.

Sheth S, Rush R, Natarajan S, Gillies M.

Clin Experiment Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.

PMID:
22452685
11.

[Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].

Le Moigne O, Duncombe A, Portmann A, Muraine M, Genevois O.

J Fr Ophtalmol. 2012 Nov;35(9):700-4. doi: 10.1016/j.jfo.2011.11.015. Epub 2012 Aug 24. French.

12.

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.

Cheng KC, Wu WC, Chen KJ.

Eye (Lond). 2009 Nov;23(11):2023-33. doi: 10.1038/eye.2009.230. Epub 2009 Oct 2.

PMID:
19798117
13.

Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.

Rahimi M, Shahrzad SS, Banifatemi M.

Iran J Immunol. 2012 Jun;9(2):136-44. doi: IJIv9i2A7.

PMID:
22735801
14.
15.

Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation.

Folgosa MS, Messias A, Takata C, Costa RA, Scott IU, Jorge R.

Acta Ophthalmol. 2010 Nov;88(7):e297-8. doi: 10.1111/j.1755-3768.2009.01721.x. No abstract available.

PMID:
19906082
16.

Acute intractable glaucoma after a single low-dose sub-Tenon's corticosteroid injection for macular edema.

Levy J, Tessler Z, Klemperer I, Lifshitz T.

Can J Ophthalmol. 2004 Oct;39(6):672-3. No abstract available.

PMID:
15559656
17.

Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.

Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.

Acta Ophthalmol. 2012 Feb;90(1):56-60. doi: 10.1111/j.1755-3768.2009.01817.x. Epub 2009 Dec 16.

PMID:
20015098
18.

Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.

Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA.

Retina. 2007 Nov-Dec;27(9):1187-95.

PMID:
18046223
19.

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.

Kim JY, Park SP.

Korean J Ophthalmol. 2009 Dec;23(4):259-65. doi: 10.3341/kjo.2009.23.4.259. Epub 2009 Dec 4.

20.

Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting.

Tabandeh H, Boscia F, Sborgia A, Ciracì L, Dayani P, Mariotti C, Furino C, Flynn HW Jr.

Retina. 2014 Jan;34(1):18-23. doi: 10.1097/IAE.0000000000000008.

PMID:
24362413
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk